Amgen Teams Up With Cambridge Biotech Community To Select Two Startups To Receive Golden Tickets At LabCentral

Amgen Golden Tickets Provide Innovative Startup Companies With Free Lab Space to Aid in Further Advancement of Their Science CAMBRIDGE, Mass., Dec. 14, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and LabCentral today announced that Kernal Biologics Inc. and QurAlis have won the Amgen Golden Ticket at LabCentral. The two Golden Ticket winners were chosen by an Amgen internal committee and live audience members at a "Quick Pitch" event hosted by Amgen at its Cambridge R&D and Operations facility on Dec. 11, 2017. Five finalists pitched their business plan to attendees where the audiences' input represented one vote of the overall results, along with the Amgen internal committee's voting ...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news